Optimal versus maximally tolerated dose in cancer chemotherapy treatment.
Markman
M
M
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D017239:Paclitaxel